SuperworthNuvation Bio shares outstanding NUVB
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 348.8M
- On a year earlier
- +2.4%
- more shares
Nuvation Bio had 348.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 344.3M | +2% |
| FY2024 | 336.9M | +54% |
| FY2023 | 219M | +0% |
| FY2022 | 218.5M | +4% |
| FY2021 | 210.2M | +70% |
| FY2020 | 123.7M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 348.8M | +2% | |
| Q1 FY26 | 377.5M | +11% | |
| Q4 FY25 | 344.3M | +2% | |
| Q3 FY25 | 342.4M | +25% | |
| Q2 FY25 | 340.7M | +39% | |
| Q1 FY25 | 338.6M | +55% | |
| Q4 FY24 | 336.9M | +54% | |
| Q3 FY24 | 273.6M | +25% | |
| Q2 FY24 | 244.7M | +12% | |
| Q1 FY24 | 219M | +0% | |
| Q4 FY23 | 219M | +0% | |
| Q3 FY23 | 218.9M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Nuvation Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.